tirzepatide filing Eli Lilly gets nod to launch weight-loss drug in Hong Kong Shifting the Scales: Tirzepatide's Breakthrough

Tirzepatide will be available for use within these specialist services immediately, should Local Health Boards wish to use it.

Where GLP-1 Receptors Are Located: Pancreas (insulin and glucagon regulation) Stomach (slowing emptying) Brain (appetite control) Heart (cardiovascular benefits) Liver (glucose production regulation) How Tirzepatide Works: Dual GIP and GLP-1 Receptor Activation: Tirzepatide activates two hormone receptors instead of one, creating a more comprehensive metabolic effect: GLP-1 Effects (Same as Semaglutide): Increased insulin secretion Decreased glucagon production Slowed gastric emptying Reduced appetite through brain signaling Enhanced satiety Additional GIP Effects: GIP (glucose-dependent insulinotropic polypeptide) adds complementary benefits: Enhanced Insulin Response: GIP amplifies insulin secretion even more than GLP-1 alone, particularly after meals when blood sugar is elevated

The SURMOUNT-1 clinical trial showed that participants on 15 mg of tirzepatide lost an average of 22.5% of their body weight over 72 weeks

Pair peptides with lifestyle habits for lasting results Peptides can support your weight loss efforts, but theyre not a substitute for the healthy habits that drive long-term success